Related Experiment Videos
MK-801 and NBQX prevent electrically induced status epilepticus
1Department of Pharmacology and Clinical Pharmacology, School of Medicine, University of Auckland, New Zealand.
Neuroreport
|July 21, 1994
Summary
N-methyl-D-aspartate (NMDA) receptor antagonists, but not muscarinic or metabotropic antagonists, prevented status epilepticus (SE) initiation in rats. This suggests NMDA receptors are key to initiating SE.
Area of Science:
- Neuroscience
- Pharmacology
- Epileptology
Background:
- Electrically induced status epilepticus (SE) is a model for studying seizure mechanisms.
- Understanding receptor involvement in SE initiation is crucial for developing treatments.
Purpose of the Study:
- To investigate the roles of muscarinic, N-methyl-D-aspartate (NMDA), and metabotropic glutamate receptors in the initiation of electrically induced status epilepticus (SE).
Main Methods:
- Tested various receptor antagonists, including scopolamine, atropine, L(+)-2-amino-3-phosphonopropionic acid (AP3), dizocilpine (MK-801), and 2,3-dihydroxy-6-nitro-7-sulphamoylbenzo(F)-quinoxaline (NBQX), in a rat model of continuous hippocampal stimulation.
- Assessed the effects of these antagonists on the initiation of SE.
Main Results:
- Muscarinic receptor antagonists (scopolamine, atropine) and the metabotropic receptor antagonist AP3 did not affect SE initiation.
- The NMDA receptor antagonist dizocilpine (MK-801) and the non-NMDA ionotropic receptor antagonist NBQX prevented SE induction.
- Previous studies indicated non-NMDA receptors are involved in SE maintenance.
Conclusions:
- NMDA receptor activation appears to be the principal initiator of electrically induced SE in this model.
- Non-NMDA ionotropic receptors may also contribute to SE initiation.
- These findings highlight the critical role of NMDA receptors in the early stages of SE.